Neurolens, Inc.
Biotechnology company · Coppell, Texas, United States
Neurolens, Inc. is a biotechnology company headquartered in Coppell, Texas, United States. Its earliest recorded incorporation is in 2012. It has reported private securities offerings to the US SEC, most recently $68 million sold in a notice filed in 2022.
Neurolens at a glance
What does Neurolens do?
Private fundraising reported to the SEC
9 Form D notices; the most recent reported $67.6 million sold (2022).
Frequently asked questions about Neurolens
Where is Neurolens headquartered?
Neurolens, Inc. is headquartered in Coppell, Texas, United States.
What does Neurolens do?
Neurolens, Inc. is a biotechnology company.
When was Neurolens founded?
The earliest incorporation on record for Neurolens, Inc. is in 2012, according to public company registers.
Similar companies
- Recursion PharmaceuticalsSalt Lake City, Utah, United States
- Vericel CorpBurlington, Massachusetts, United States
- SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
- Adaptive Biotechnologies CorpSeattle, Washington, United States
- Inhibikase Therapeutics, Inc.Wilmington, Delaware, United States
- Cognition Therapeutics IncPurchase, New York, United States
- Agenus IncLexington, Massachusetts, United States
- Vaxcyte, Inc.San Carlos, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences